A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Coherus Oncology, Inc.
Vividion Therapeutics, Inc.
Harbinger Health
BioNTech SE
AbbVie
NeoImmuneTech
Alterome Therapeutics, Inc.
Eisai Inc.
BioNTech SE
Psyence Australia Pty Ltd
Cartography Biosciences
Boston Scientific Corporation
Coherus Oncology, Inc.
ViroMissile, Inc.
Eisai Inc.
Replimune Inc.
Amgen
Eisai Inc.
Lokon Pharma AB
Pfizer
Astellas Pharma Inc
AstraZeneca
A2 Biotherapeutics Inc.
Boston Scientific Corporation
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Astellas Pharma Inc
Nouscom SRL
A2 Biotherapeutics Inc.
Amgen
Angiex, Inc.
Astellas Pharma Inc
Pfizer
Iambic Therapeutics, Inc
Pheon Therapeutics
Pheon Therapeutics
iOMEDICO AG
DualityBio Inc.
EXoPERT
Conjupro Biotherapeutics, Inc.
inTumo Therapeutics, Inc.
Ocellaris Pharma, Inc.
AgonOx, Inc.
Elephas
GlaxoSmithKline
Immunophotonics, Inc.
Eli Lilly and Company
Novartis
Dysplasia Diagnostics Limited